1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Bersch, B. Hernandez, J.-F. Marion, D. Arlaud, G.J. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 37 1204 1214 10.1021/bi971851v 9477945 Solution structure of the epidermal growth factor (EGF)-like module of human complement protease C1r, an atypical member of the EGF family. 1998 DK J.Pept.Res. JPERFA 2150 1397-002X 49 221 Chemical Synthesis and Characterization of the Egf-Like Module of Human Complement Protease C1R 1997 10.2210/pdb1apq/pdb pdb_00001apq 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 CALCIUM-BINDING CONSENSUS SEQUENCE 5984.458 COMPLEMENT PROTEASE C1R 3.4.21.41 EGF-LIKE MODULE 1 man polymer no no AVDLDECASRSKSGEEDPQPQCQHLCHNYVGGYFCSCRPGYELQEDRHSCQAE AVDLDECASRSKSGEEDPQPQCQHLCHNYVGGYFCSCRPGYELQEDRHSCQAE A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo sample 9606 Homo sapiens database_2 pdbx_database_status pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations Other 1 0 1997-09-17 1 1 2008-03-24 1 2 2011-07-13 1 3 2022-02-16 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site _pdbx_nmr_software.name Y BNL 1997-07-22 REL REL EXPERIMENTAL ENERGY 25 19 NOESY 6.7 288 K REFINEMENT DETAILS CAN BE FOUND IN THE FOLLOWING JOURNAL CITATION : BLACKLEDGE ET AL., J. MOL. BIOL. 245, 661-681 (1995). SIMULATED ANNEALING, RESTRAINED MOLECULAR DYNAMICS BIOSYM refinement DISCOVER (MODIFICATION OF ST ST structure solution Discover 600 Bruker AMX-600 ALA 23 n 1 ALA 23 A VAL 24 n 2 VAL 24 A ASP 25 n 3 ASP 25 A LEU 26 n 4 LEU 26 A ASP 27 n 5 ASP 27 A GLU 28 n 6 GLU 28 A CYS 29 n 7 CYS 29 A ALA 30 n 8 ALA 30 A SER 31 n 9 SER 31 A ARG 32 n 10 ARG 32 A SER 33 n 11 SER 33 A LYS 34 n 12 LYS 34 A SER 35 n 13 SER 35 A GLY 36 n 14 GLY 36 A GLU 37 n 15 GLU 37 A GLU 38 n 16 GLU 38 A ASP 39 n 17 ASP 39 A PRO 40 n 18 PRO 40 A GLN 41 n 19 GLN 41 A PRO 42 n 20 PRO 42 A GLN 43 n 21 GLN 43 A CYS 44 n 22 CYS 44 A GLN 45 n 23 GLN 45 A HIS 46 n 24 HIS 46 A LEU 47 n 25 LEU 47 A CYS 48 n 26 CYS 48 A HIS 49 n 27 HIS 49 A ASN 50 n 28 ASN 50 A TYR 51 n 29 TYR 51 A VAL 52 n 30 VAL 52 A GLY 53 n 31 GLY 53 A GLY 54 n 32 GLY 54 A TYR 55 n 33 TYR 55 A PHE 56 n 34 PHE 56 A CYS 57 n 35 CYS 57 A SER 58 n 36 SER 58 A CYS 59 n 37 CYS 59 A ARG 60 n 38 ARG 60 A PRO 61 n 39 PRO 61 A GLY 62 n 40 GLY 62 A TYR 63 n 41 TYR 63 A GLU 64 n 42 GLU 64 A LEU 65 n 43 LEU 65 A GLN 66 n 44 GLN 66 A GLU 67 n 45 GLU 67 A ASP 68 n 46 ASP 68 A ARG 69 n 47 ARG 69 A HIS 70 n 48 HIS 70 A SER 71 n 49 SER 71 A CYS 72 n 50 CYS 72 A GLN 73 n 51 GLN 73 A ALA 74 n 52 ALA 74 A GLU 75 n 53 GLU 75 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O LEU 47 A O LEU 25 A N SER 58 A N SER 36 3 A TYR 63 0.082 SIDE CHAIN 3 A ARG 69 0.099 SIDE CHAIN 4 A ARG 60 0.080 SIDE CHAIN 5 A TYR 63 0.101 SIDE CHAIN 6 A PHE 56 0.093 SIDE CHAIN 8 A HIS 46 0.095 SIDE CHAIN 9 A TYR 55 0.081 SIDE CHAIN 12 A TYR 55 0.063 SIDE CHAIN 12 A TYR 63 0.089 SIDE CHAIN 13 A TYR 55 0.123 SIDE CHAIN 13 A TYR 63 0.140 SIDE CHAIN 15 A HIS 46 0.099 SIDE CHAIN 19 A TYR 55 0.112 SIDE CHAIN 19 A TYR 63 0.116 SIDE CHAIN 19 A ARG 69 0.101 SIDE CHAIN 1 7.50 1.10 114.20 121.70 A A A CA CB SG CYS CYS CYS 48 48 48 N 2 7.61 1.10 114.20 121.81 A A A CA CB SG CYS CYS CYS 48 48 48 N 9 8.12 1.10 114.20 122.32 A A A CA CB SG CYS CYS CYS 48 48 48 N 12 6.85 1.10 114.20 121.05 A A A CA CB SG CYS CYS CYS 48 48 48 N 15 6.90 1.10 114.20 121.10 A A A CA CB SG CYS CYS CYS 48 48 48 N 18 6.83 1.10 114.20 121.03 A A A CA CB SG CYS CYS CYS 48 48 48 N 19 8.25 1.10 114.20 122.45 A A A CA CB SG CYS CYS CYS 48 48 48 N 1 A SER 33 53.03 -149.18 1 A ASP 39 -168.71 117.58 1 A GLN 43 -59.33 102.96 1 A CYS 44 73.61 53.63 1 A HIS 46 -101.64 -83.58 1 A PRO 61 -47.02 156.67 1 A HIS 70 -158.21 -37.50 2 A VAL 24 76.40 -56.77 2 A LEU 26 -55.50 174.64 2 A ASP 27 65.93 92.59 2 A GLU 28 -153.07 -60.08 2 A ARG 32 49.42 -110.84 2 A LYS 34 67.95 -62.60 2 A SER 35 -151.59 57.15 2 A GLU 38 76.41 151.90 2 A ASP 39 -154.85 75.78 2 A PRO 42 -17.80 90.21 2 A GLN 45 -6.97 -62.45 2 A HIS 46 -88.00 -79.97 2 A ARG 69 85.26 43.17 3 A SER 35 28.62 65.93 3 A GLU 37 66.45 -70.05 3 A ASP 39 166.44 130.96 3 A GLN 43 68.13 -1.10 3 A GLN 45 -31.44 -85.66 3 A HIS 46 -124.87 -72.89 3 A PHE 56 -92.93 -72.04 3 A CYS 57 104.34 167.36 3 A HIS 70 -152.14 -27.41 4 A GLU 28 -36.73 99.27 4 A ALA 30 -120.48 -75.73 4 A ARG 32 63.28 168.82 4 A SER 35 -68.42 71.40 4 A ASP 39 -155.54 -61.42 4 A PRO 42 -54.95 170.93 4 A GLN 43 -77.51 -111.31 4 A CYS 44 156.16 164.19 4 A HIS 46 -105.36 -94.12 5 A GLU 28 -39.26 -36.12 5 A SER 35 -150.33 -11.98 5 A ASP 39 -166.20 92.16 5 A GLN 43 -58.92 109.42 5 A GLN 45 -60.44 -96.12 5 A HIS 46 -83.46 -82.36 5 A GLU 67 73.36 -52.00 5 A ASP 68 114.13 -24.19 6 A SER 33 -170.76 -63.15 6 A LYS 34 -63.94 77.53 6 A SER 35 -157.25 -68.90 6 A ASP 39 71.81 80.93 6 A HIS 46 -96.21 -75.19 6 A PHE 56 -112.15 -77.66 6 A CYS 57 97.03 166.70 6 A HIS 70 -150.09 -45.43 7 A GLN 43 -75.29 39.62 7 A CYS 44 -178.16 135.42 7 A HIS 46 -107.40 -90.58 7 A TYR 51 -173.04 -174.55 7 A ARG 69 75.05 -32.05 8 A GLU 28 -60.49 70.88 8 A CYS 29 -174.37 -63.59 8 A LYS 34 61.91 60.53 8 A ASP 39 71.71 107.46 8 A PRO 42 -73.92 -167.68 8 A HIS 46 -107.83 -76.60 8 A TYR 51 -177.19 -178.72 8 A GLU 67 -58.92 -0.70 8 A ARG 69 72.66 -27.97 9 A GLU 28 177.99 93.20 9 A CYS 29 68.82 -64.00 9 A GLU 38 -176.07 -169.75 9 A HIS 46 -107.06 -84.74 9 A ASP 68 -153.35 -14.56 9 A ARG 69 73.67 -34.26 9 A ALA 74 -86.31 45.10 10 A ASP 25 108.52 161.83 10 A ASP 27 -59.27 103.34 10 A LYS 34 -64.34 78.54 10 A SER 35 -156.68 47.57 10 A GLU 37 -37.56 94.12 10 A CYS 44 -59.45 101.62 10 A HIS 46 -95.35 -82.63 10 A HIS 70 -131.51 -42.92 11 A LEU 26 44.52 -137.55 11 A ASP 27 -100.84 73.32 11 A ARG 32 47.39 -62.02 11 A SER 33 -171.30 30.01 11 A SER 35 -77.05 48.30 11 A PRO 42 -49.03 105.46 11 A CYS 44 124.68 94.62 11 A HIS 46 -95.72 -83.76 11 A TYR 51 -177.41 -171.74 11 A ARG 69 75.95 -39.58 12 A LEU 26 -92.37 -157.96 12 A CYS 29 -103.94 58.68 12 A SER 31 69.26 -57.58 12 A ARG 32 69.61 -59.89 12 A SER 33 -164.28 -167.77 12 A GLU 38 36.15 52.32 12 A ASP 39 -146.12 -59.33 12 A GLN 41 98.76 138.57 12 A HIS 46 -94.84 -92.72 12 A ARG 69 76.00 -3.02 13 A VAL 24 73.44 -51.48 13 A ARG 32 -79.74 48.86 13 A GLU 37 -43.37 106.26 13 A ASP 39 -161.37 77.74 13 A HIS 46 -108.25 -90.09 13 A TYR 51 -171.56 -174.95 13 A GLU 67 -59.52 -9.32 13 A ARG 69 74.22 -31.65 14 A GLU 28 34.97 39.60 14 A CYS 29 55.63 16.21 14 A LYS 34 -50.78 105.70 14 A GLU 37 52.80 -97.48 14 A ASP 39 -167.11 90.17 14 A GLN 41 -118.68 74.87 14 A PRO 42 -80.74 46.12 14 A CYS 44 89.79 91.95 14 A HIS 46 -110.15 -87.99 15 A CYS 29 -173.03 38.39 15 A ARG 32 -60.59 84.25 15 A SER 33 -68.64 26.84 15 A LYS 34 -178.70 144.40 15 A SER 35 64.96 -65.58 15 A GLU 38 -68.60 69.58 15 A GLN 41 71.39 130.39 15 A PRO 42 -52.04 98.03 15 A HIS 46 -107.31 -70.61 15 A GLU 67 49.93 71.16 15 A ARG 69 66.72 63.33 15 A HIS 70 -144.53 -36.13 16 A SER 35 -161.37 -80.57 16 A GLN 41 31.54 67.68 16 A PRO 42 -71.93 -159.88 16 A HIS 46 -111.64 -77.14 16 A GLU 67 -57.82 -9.17 16 A ARG 69 82.02 26.19 16 A HIS 70 -147.65 -43.89 17 A CYS 29 77.72 -48.89 17 A ALA 30 -57.14 -72.60 17 A ARG 32 -47.59 -19.71 17 A SER 33 -154.21 58.21 17 A LYS 34 64.87 -77.19 17 A ASP 39 -170.15 135.03 17 A PRO 42 -68.99 75.97 17 A HIS 46 -106.86 -68.38 17 A TYR 51 -174.61 -174.26 17 A SER 58 -131.55 -55.87 17 A CYS 59 105.03 175.07 17 A HIS 70 -141.91 -47.05 18 A LYS 34 92.26 68.12 18 A HIS 46 -109.56 -87.70 18 A TYR 51 -177.71 -176.25 18 A ASP 68 -171.38 -17.01 18 A ALA 74 -85.14 44.04 19 A LEU 26 -110.20 -152.33 19 A CYS 29 -146.48 53.62 19 A ALA 30 76.26 -93.02 19 A ARG 32 69.27 -63.79 19 A SER 33 72.78 -37.36 19 A LYS 34 -67.08 74.40 19 A SER 35 -58.42 -80.06 19 A GLU 37 -68.42 85.31 19 A GLU 38 -69.15 68.16 19 A HIS 46 -101.60 -79.02 19 A GLU 67 69.99 -17.81 19 A ASP 68 75.64 -3.98 19 A HIS 70 -164.25 -47.90 STRUCTURE OF THE EGF-LIKE MODULE OF HUMAN C1R, NMR, 19 STRUCTURES 1 Y N disulf 2.077 A CYS 29 A SG CYS 7 1_555 A CYS 48 A SG CYS 26 1_555 disulf 2.073 A CYS 44 A SG CYS 22 1_555 A CYS 57 A SG CYS 35 1_555 disulf 2.074 A CYS 59 A SG CYS 37 1_555 A CYS 72 A SG CYS 50 1_555 COMPLEMENT COMPLEMENT, EGF, CALCIUM BINDING, SERINE PROTEASE C1R_HUMAN UNP 1 1 P00736 MWLLYLLVPALFCRAGGSIPIPQKLFGEVTSPLFPKPYPNNFETTTVITVPTGYRVKLVFQQFDLEPSEGCFYDYVKISA DKKSLGRFCGQLGSPLGNPPGKKEFMSQGNKMLLTFHTDFSNEENGTIMFYKGFLAYYQAVDLDECASRSKSGEEDPQPQ CQHLCHNYVGGYFCSCRPGYELQEDRHSCQAECSSELYTEASGYISSLEYPRSYPPDLRCNYSIRVERGLTLHLKFLEPF DIDDHQQVHCPYDQLQIYANGKNIGEFCGKQRPPDLDTSSNAVDLLFFTDESGDSRGWKLRYTTEIIKCPQPKTLDEFTI IQNLQPQYQFRDYFIATCKQGYQLIEGNQVLHSFTAVCQDDGTWHRAMPRCKIKDCGQPRNLPNGDFRYTTTMGVNTYKA RIQYYCHEPYYKMQTRAGSRESEQGVYTCTAQGIWKNEQKGEKIPRCLPVCGKPVNPVEQRQRIIGGQKAKMGNFPWQVF TNIHGRGGGALLGDRWILTAAHTLYPKEHEAQSNASLDVFLGHTNVEELMKLGNHPIRRVSVHPDYRQDESYNFEGDIAL LELENSVTLGPNLLPICLPDNDTFYDLGLMGYVSGFGVMEEKIAHDLRFVRLPVANPQACENWLRGKNRMDVFSQNMFCA GHPSLKQDACQGDSGGVFAVRDPNTDRWVATGIVSWGIGCSRGYGFYTKVLNYVDWIKKEMEEED 140 192 1APQ 23 75 P00736 A 1 1 53 2 anti-parallel A LEU 47 A LEU 25 A TYR 51 A TYR 29 A GLY 54 A GLY 32 A SER 58 A SER 36 PROBABLE CALCIUM BINDING SITE. Unknown 5 A ASP 25 A ASP 3 5 1_555 A LEU 26 A LEU 4 5 1_555 A GLU 28 A GLU 6 5 1_555 A ASN 50 A ASN 28 5 1_555 A TYR 51 A TYR 29 5 1_555 1 P 1